Biovica publishes a description of study-results in breast cancer with DiviTum®
(WorldNews Sweden)

Biovica has a comprehensive study program with DiviTum® to demonstrate the clinical value for cancer patients. Biovica has published a description brochure in order to share knowledge about results achieved so far with DiviTum® to researchers, oncologists and other stakeholders. The description describes all clinical studies presented where DiviTum® is used to evaluate response to breast cancer treatment. DiviTum® has to date been investigated in seventeen clinical studies, of which eight were within the breast cancer area. In breast cancer, over 1,000 patients have participated, where the majority have been patients with metastatic breast cancer (n=845), but also a large number of patients with...